>> 全站文章索引 >> 第44页:
  • 第二代抗精神病药和糖尿病的关系：潜在风险评估和临床印象 - [.]
  • 瑞典精神疾病与代谢风险的相关性研究 - [.]
  • 精神分裂症门诊患者的体重增加和代谢性并发症对健康相关生活质量的影响 - [.]
  • 糖尿病共病抑郁症患者的成本－效果分析 - [.]
  • 舍曲林在老年和青年糖尿病患者中预防抑郁复发的疗效 - [.]
  • Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine - [Paile-Hyvarinen, M; Wahlbeck, K; Eriksson, J G]
  • Mood disorders: Cardiovascular and diabetes comorbidity - [Fenton, W. S. and E. S. Stover]
  • A growth in bipolar disorder? - [J.Xu , I.-A. Rasmussen1, E. M. Berntsen1, K. Moss, R. Shnier, J. Lagopoulos, G. S. Malhi]
  • 美国精神病学协会(APA)第160届年会简介 - [季建林 教授]
  • 儿童的睡眠问题和焦虑、抑郁 - [Johnson EO. Chilcoat HD. Breslau N]
  • 原发性失眠中应激症状和抑郁症状是睡眠的相关因素 - [Hall M. Buysse DJ. Nowell PD. Nofzinger EA. Houck P. Reynolds CF 3rd. Kupfer DJ.]
  • 抑郁状态时失眠的病理生理机制及其处理 [综述87篇参考文献] - [Kupfer DJ.]
  • 失眠、抑郁和死亡的关系：对社区老人12年的随访 - [Mallon L. Broman JE. Hetta J.]
  • 焦虑症、抑郁症和失眠 [综述130篇参考文献] - [Shaver JL. Johnston SK. Lentz MJ. Landis CA.]
  • 失眠的中年妇女中应激暴露、心理痛苦和生理应激的激活 - [Shaver JL. Johnston SK. Lentz MJ. Landis CA.]
  • 癌症化疗病人的失眠、疲乏、焦虑、抑郁和生活质量 - [Redeker NS. Lev EL. Ruggiero J.]
  • 1950年至1960年间荷兰女性杂志’Margriet’上登载关于抑郁、焦虑和失眠的医学信息分析 [荷兰语] - [Uttien J. Pieters T. Meijman FJ.]
  • 失眠的维持治疗：从有关抑郁症的文献中我们能学到什么？[综述106篇参考文献] - [Jindal RD. Buysse DJ. Thaes ME.]
  • 失眠、抑郁症和衰老：老年人睡眠与情绪相互作用的评估 [综述39篇参考文献] - [Buysse DJ.]
  • 美国糖尿病患者生活质量的前瞻性研究 - [Smith DW.]
  • 锻炼为基础的干预方式改善心理健康和生活质量有效性的评估：随机对照研究 - [Atlantis E, Chow CM, Kirby A, Singh MF.]
  • 机动车车祸后幸存者生活质量和创伤后的症状群：抑郁和焦虑的中介效应 - [Gudmundsdottir B, Beck JG, Coffey SF, Miller L]
  • 欧洲心脏疾病生活质量项目：国际研究以心脏疾病为核心相关的生活质量问卷（HeartQoL）的编制 - [Oldridge N, Saner H, McGee HM]
  • 重大创伤影响：女性生活质量影响大于男性，并非为作用机制与创伤严重程度所致 - [Holbrook TL, Hoyt DB]
  • 改善老年共病躯体疾病患者的抑郁后果 - [Harpole LH, Williams JW Jr, Olsen MK, Stechuchak KM, Oddone E, Callahan CM, Katon WJ, Lin EH, Grypma]
  • 早期童年因素对青少年健康相关生活质量的影响：随访13年 - [Wilkins AJ, O]
  • 腹膜透析病人的生活质量及其心理问题 - [Lew SQ, Piraino B.]
  • 消化系统肿瘤病人的心理状态、生活质量和应对方式 - [Matsushita T, Matsushima E, Maruyama M.]
  • 造血干细胞移植术后常规筛查心理社会应激 - [Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, Cutler C, Ho VT, Richardson PG, Sc]
  • Alzheimer型痴呆病人高血压与其认知功能减退速率 - [Bellew KM, Pigeon JG, Stang PE, Fleischman W, Gardner RM, Baker WW.]
  • 金刚烷胺（Memantine）治疗痴呆 - [Areosa Sastre A, McShane R, Sherriff F.]
  • 加兰他敏（Galantamine）治疗阿尔茨海默病 - [Loy C, Schneider L.]
  • 有关胆碱酯酶抑制剂多奈哌齐（Donepezil）治疗痴呆的系统文献综述 - [Kaduszkiewicz H, Beck-Bornholdt HP, van den Bussche H, Zimmermann T.]
  • 金刚烷胺对阿尔茨海默病的治疗地位：需要治疗病人数（NTT）分析 - [Livingston G, Katona C]
  • 胆碱酯酶抑制剂治疗阿尔茨海默病的比较研究 - [Hogan DB, Goldlist B, Naglie G, Patterson C.]
  • 多奈哌齐治疗中到重度阿尔茨海默病：对随机对照试验中的病人个体数据进行meta分析 - [Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG.]
  • 多奈哌齐, 加兰他敏和 rivastigmine治疗阿尔茨海默病的效力和安全性的随机对照试验研究的meta分析 - [Ritchie CW, Ames D, Clayton T, Lai R]
  • 银杏叶提取物Ginkgo biloba和胆碱酯酶抑制剂治疗痴呆的比较：基于cochrane协作网的meta分析结果的综述 - [Kurz A, Van Baelen B]
  • 多奈哌齐治疗血管性痴呆 - [Malouf R, Birks J]
  • 他汀类及其它降脂药与痴呆患病的风险 - [Rockwood K, Darvesh S.]
  • 胆碱酯酶抑制剂治疗阿尔茨海默病的效力和安全性的meta分析 - [Lanctot KL, Herrmann N, Yau KK, Khan LR, Liu BA, LouLou MM, Einarson TR.]
  • 卵磷脂对痴呆及认知功能损害治疗 - [Higgins JP, Flicker L.]
  • 对加兰他敏在英国治疗阿尔茨海默病的卫生经济学评价 - [Ward A, Caro JJ, Getsios D, Ishak K, O]
  • 乙酰-L-肉毒碱治疗轻度认知功能损害和轻度阿尔茨海默病的双盲随机对照临床试验的mata-分析 - [Montgomery SA, Thal LJ, Amrein R.]
  • 长春西汀（Vinpocetine）治疗认知功能损害和痴呆 - [Szatmari SZ, Whitehouse PJ.]
  • 司来吉兰（Selegiline）治疗阿尔茨海默病 - [Birks J, Flicker L.]
  • 对胆碱酯酶抑制剂治疗阿尔茨海默病的神经精神症状及功能损害的效力的meta分析 - [Trinh NH, Hoblyn J, Mohanty S, Yaffe K.]
  • Efficacy of Duloxetine on Cognition, Depression, and Pain in Elderly Patients With Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled Trial - [Joel Raskin, M.D., F.R.C.P.C., Curtis G. Wiltse, Ph.D., Alan Siegal, M.D., M.B.A., Javaid Sheikh, M.]
  • The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis - [Guilherme Polanczyk, M.D., Maur¨ªcio Silva de Lima, M.D., Ph.D., Bernardo Lessa Horta, M.D., Ph.D.,]
  • The FDA Pediatric Advisories and Changes in Diagnosis and Treatment of Pediatric Depression - [Cynthia R. Pfeffer, M.D.]
  • Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy - [Jeffery A Lieberman1, Joel Greenhouse2, Robert M Hamer3, K Ranga Krishnan4, Charles B Nemeroff5, Dav]
  • Music therapy for schizophrenia or schizophrenia-like illnesses - [C Gold, TO Heldal, T Dahle, T Wigram]
  • Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients - [Mark Zetin,MD, Cara T. Hoepner, RN, and Lynda Bjornson, PhD]
  • Interpersonal problems and emotional intelligence in compulsive hoarding - [Jessica R. Grisham, Ph.D., Gail Steketee, Ph.D., Randy O. Frost, Ph.D.]
  • Twelve-Month Outcome of Adolescents With Bipolar Disorder Following First Hospitalization for a Manic or Mixed Episode - [Melissa P. DelBello, M.D., M.S., Dennis Hanseman, Ph.D., Caleb M. Adler, M.D., David E. Fleck, Ph.D.]
  • What Have We Learned About the Neurobiology of Major Depression? - [Maria A. Oquendo, M.D. and Ramin V. Parsey, M.D.]
  • Social anxiety and insomnia: the mediating role of depressive symptoms - [Julia D. Buckner, Rebecca A. Bernert,Kiara R. Cromer, Thomas E. Joiner,Norman B. Schmidt]
  • Maternal anxiety- course and antecedents during the early postpartum period - [John R. Britton, M.D, Ph.D]
  • New generation antipsychotics for first episode schizophrenia - [C Rummel, J Hamann, W Kissling, S Leucht]
  • Early identification and high-risk strategies for bipolar disorder - [Christoph U Corrella,b, Julie B Penznerc, et al]
  • Generalized anxiety disorder: a 40-year follow-up study - [G. Rubio, J. J. L¨®pez-Ibor]
  • SSRIs antidepressant activity is influenced by Gβ3 variants - [Alessandro Serretti, Cristina Lorenzi, Cristina Cusin, Raffaella Zanardi, Enrico Lattuada, David Rossini, Roberta Lilli, Adele Pirovano, Marco Catalano and Enrico Smeraldi]
  • Pharmacokinetics of selective serotonin reuptake inhibitors - [Christoph Hiemke and Sebastian H?rtter]
  • Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection - [Chien-Tsai Lai, Emily S. Gordon, Sidney H. Kennedy, Alan N. Bateson, Ronald T. Coutts and Glen B. Baker]
  • Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment - [David Michelson, Jay Amsterdam, Jeffrey Apter, Maurizio Fava, Peter Londborg, Roy Tamura and Lisa Pagh]
  • Anxiolytic-Like Effects of Antidepressants After Acute Administration in a Four-Plate Test in Mice - [Martine Hasco?t, Michel Bourin, Marie Claude Colombel, Alexandra J. Fiocco and Glen B. Baker]
  • A novel serotonin transporter ligand: (5-Iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol - [Zhi-Ping Zhuang, Seok-Rye Choi, Catherine Hou, Mu Mu, Mei-Ping Kung, Paul D. Acton and Hank F. Kung]
  • Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood - [Gunther H. Moll, Claas Mehnert, Maike Wicker, Nathalie Bock, Aribert Rothenberger, Eckart Rüther and Gerald Huether]
  • Effects of repeated phencyclidine treatment on serotonin transporter in rat brain - [Takafumi Hori, Shuzo Abe, Atsuomi Baba, Toshihito Suzuki and Hiroyasu Shiraishi]
  • Aging regulates 5-HT1B receptors and serotonin reuptake sites in the SCN - [Marilyn J. Duncan, Charles J. Crafton and Deborah L. Wheeler]
  • The effects of St. John's Wort (Hypericum perforatum) on NK cell activity in vitro - [C. M. Helgason, J. L. Wieseler Frank, D. R. Johnson, M. G. Frank and S. E. Hendricks]
  • Gas chromatographic–mass spectrometric procedures for determination of the catechol-O-methyltransferase (COMT) activity and for detection of unstable catecholic metabolites in human and rat liver preparations after COMT catalyzed in statu nascendi derivat - [Hans H. Maurer, Joerg Bickeboeller-Friedrich and Thomas Kraemer]
  • Effect of Subchronic Antidepressant Treatments on Behavioral, Neurochemical, and Endocrine Changes in the Forced-Swim Test - [Thomas J. Connor, Padraig Kelliher, Yan Shen, Andrew Harkin, John P. Kelly and Brian E. Leonard]
  • 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand - [Shunichi Oya, Seok-Rye Choi, Catherine Hou, Mu Mu, Mei-Ping Kung, Paul D. Acton, Michael Siciliano and Hank F. Kung]
  • Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia - [.]
  • Antimicrobial activity of psychotropic drugs: Selective serotonin reuptake inhibitors - [J. L. Munoz-Bellido, S. Munoz-Criado and J. A. Garcìa-Rodrìguez]
  • Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat - [Yves Charnay, Isabelle Cusin, Philippe G. Vallet, Patrick Muzzin, Fran?oise Rohner-Jeanrenaud and Constantin Bouras]
  • Paroxetine binding in aggressive schizophrenic patients - [Ilan Modai, Anatoly Gibel, Boris Rauchverger, Michael Ritsner, Ehud Klein and Dorit Ben-Shachar]
  • Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers - [R. Schl?sser, H. Wetzel, H. D?rr, W. Rossbach, Ch. Hiemke and O. Benkert]
  • Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain - [C. Vilpoux, I. Leroux-Nicollet, L. Naudon, R. Raisman-Vozari and J. Costentin]
  • Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain - [Agnès Besson, Nasser Haddjeri, Pierre Blier and Claude de Montigny]
  • Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial - [Pinhas N. Dannon, Yehuda Sasson, Shmuel Hirschmann, Iulian Iancu, Leon J. Grunhaus and Joseph Zohar]
  • Paroxetine binding to the rat norepinephrine transporter in vivo - [Michael J. Owens, David L. Knight and Charles B. Nemeroff]
  • The serotonin transporter in the midbrain of suicide victims with major depression - [William Bligh-Glover, Tamara N. Kolli, Laura Shapiro-Kulnane, Ginny E. Dilley, Lee Friedman, Elizabeth Balraj, Grazyna Rajkowska and Craig A. Stockmeier]
  • Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography - [E. Lacassie, J. -M. Gaulier, P. Marquet, J. -F. Rabatel and G. Lachatre]
  • Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain - [Frank I. Tarazi, Kehong Zhang and Ross J. Baldessarini]
  • Serotonin Reuptake Is Less Efficient in Taste Aversion Resistant Than in Taste Aversion-Prone Rats - [R. L. Elkins, T. E. Orr, J. Q. Li, P. A. Walters, J. L. Whitford, G. F. Carl and J. L. Rausch]
  • Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study - [Murray B. Stein, G. Ron Norton, John R. Walker, Mariette J. Chartier and Roger Graham]
  • The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared - [R. A. Lawrenson, F. Tyrer, R. B. Newson and R. D. T. Farmer]
  • Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression - [Maurizio Fava, Jerrold F. Rosenbaum, Sharon L. Hoog, Rosalinda G. Tepner, Joan B. Kopp and Mary E. Nilsson]
  • Open-label trial of paroxetine in children with obsessive-compulsive disorder - [Rasim Somer Diler and Ayse Avci]
  • The question of feedback at the somadendritic region and antidepressant drug action - [Stanley Kalsner]
  • Thalamic volume in pediatric obsessive–compulsive disorder patients before and after cognitive behavioral therapy - [David R. Rosenberg, Nili R. Benazon, Andrew Gilbert, April Sullivan and Gregory J. Moore]
  • 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation - [Yukihiko Shirayama, Kenji Hashimoto, Masaomi Iyo, Kei-ichiro Watanabe, Teruhiko Higuchi and Yoshio Minabe]
  • The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test - [Martine Hasco?t, Michel Bourin and Brid A. Nic Dhonnchadha]
  • Chronic prenatal exposure to paroxetine (Paxil) and cognitive development of mice offspring - [H. Dix Christensen, William F. Rayburn and Christina L. Gonzalez]
  • Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat - [Jean-Claude Bé?que, Claude de Montigny, Pierre Blier and Guy Debonnel]
  • Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults - [M. Philipp, J. W. G. Tiller, D. Baier and R. Kohnen]
  • Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis - [Isabelle Malagié, Antoine Deslandes and Alain M. Gardier]
  • Modification of presynaptic CaM kinase II affinity for ATP in hippocampus after long term blockade of serotonin reuptake - [Elena Consogno, Cinzia Dorigo, Giorgio Racagni and Maurizio Popoli]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 [44] 45 46 47 48 49 50